Part of The University of Texas System
Part of the University of Texas System
Friday, May 1, 2020
KABB: ‘Promising’ treatment for COVID-19 being tested with San Antonio patients
Dr. Thomas Patterson, chief of infectious diseases and PI of the remdesivir clinical trial site locally, discusses the promising early results of the drug in the fight against COVID-19. Read the full story.